Colorectal Cancer

Colorectal Cancer: treatments, trials & survival

Colorectal cancer is the third most common cancer in the US. See 5-year survival rates by stage, cure-rate context, screening guidance, treatments, and clinical trials for colon and rectal cancer.

New Cases (2024)
152,810
5-Yr Survival
65.1%
Annual Deaths
53,010
Trend
Increasing in younger adults
See active trials

About Colorectal Cancer

Colorectal cancer is the third most common cancer in the US. See 5-year survival rates by stage, cure-rate context, screening guidance, treatments, and clinical trials for colon and rectal cancer.

According to the National Cancer Institute’s SEER database, an estimated 152,810 new cases of colorectal cancer will be diagnosed in the United States in 2024, with approximately 53,010 deaths. The overall 5-year relative survival rate is 65.1%.

Source: NCI SEER Data: 1975–2022

Colorectal Cancer survival rates by stage

5-year relative survival is the standard public statistic for comparing outcomes. Figures below are approximate US SEER ranges used for patient education — your personal prognosis depends on exact stage, tumor biology, and treatment response.

Stage / extent Approx. 5-year relative survival What it usually means
Localized (confined to colon/rectum) ~91% Highest cure potential when found before spread to lymph nodes
Regional (nearby lymph nodes) ~73% Often treated with surgery plus chemotherapy
Distant (metastatic / Stage IV) ~14–16% Systemic therapy, targeted drugs, and trials are central
All stages combined 65.1% NCI SEER 5-year relative survival (US)

Source: NCI SEER Stat Facts (rounded for readability). Always confirm the latest figures and your stage grouping with your care team.

Colorectal cancer survival rates by stage

People searching for a “colorectal cancer cure rate” are usually asking about long-term survival. Oncologists more often cite the 5-year relative survival rate — how many people with this cancer are alive five years after diagnosis compared with people of the same age without the cancer. Stage at diagnosis is the strongest driver of that number.

Cure rate vs survival rate — what the words mean

“Cure rate” is not a single official SEER statistic. In everyday language it often means lasting remission with no evidence of disease. Survival rates are population averages from SEER and similar registries. A person with Stage I disease may have a very high chance of durable cure after surgery; someone with Stage IV disease may still live years with modern therapy even when “cure” is less likely. Ask your oncology team how your stage, MSI/MMR status, and treatment plan map onto prognosis — not a headline percentage alone.

Rectal cancer vs colon cancer survival

Colon and rectal cancers are often grouped as “colorectal,” but rectal tumors may involve radiation and different surgical approaches. Overall SEER figures combine both. If you were diagnosed with rectal cancer specifically, ask for stage-specific numbers and whether neoadjuvant (pre-surgery) therapy is planned — that sequence has changed outcomes for many patients.

Treatment options

Current treatment approaches for colorectal cancer depend on the stage at diagnosis, tumor characteristics, and the patient’s overall health. The most common options include:

1
Surgery (Colectomy)
2
Chemotherapy (FOLFOX, FOLFIRI)
3
Radiation Therapy
4
Targeted Therapy (Bevacizumab, Cetuximab)
5
Immunotherapy (MSI-H/dMMR)
6
Ablation

Treatment recommendations should always be discussed with a qualified oncologist. The options listed above are based on current clinical guidelines and may vary case by case.

Stages

Staging describes the extent of cancer in the body and is crucial for planning the most appropriate treatment:

Stage 0 Stage I Stage II Stage III Stage IV

Known risk factors

Understanding risk factors can support prevention and early detection. Known risk factors for this cancer include:

Age
Inflammatory bowel disease
Family history
Lynch syndrome
Diet low in fiber
Obesity
Smoking

Not sure where to start?

A patient navigator familiar with colorectal cancer can help you understand your options and connect you with top US hospitals. Free & confidential.

Active clinical trials

Clinical trials offer access to cutting-edge treatments not yet widely available. The trials below are sourced in real time from ClinicalTrials.gov:

Frequently asked questions

The overall 5-year relative survival rate for colorectal cancer in the US is about 65.1% (NCI SEER). Localized disease is near 91%; regional disease near 73%; distant (metastatic) disease roughly 14–16%.
There is no single national “cure rate.” For early-stage (localized) disease, most patients are treated with curative intent and long-term disease-free survival is high. For Stage IV disease, treatment often aims at control and longevity rather than guaranteed cure. Your care team can interpret numbers for your stage and tumor biology.
Stage II disease is typically regionalized in SEER groupings. Many Stage II patients have favorable outcomes after surgery, with or without adjuvant chemotherapy depending on high-risk features. Exact percentages vary by T stage, MSI status, and other factors — discuss your pathology report with your oncologist.
Distant-stage (metastatic) 5-year relative survival is roughly 14–16% in SEER data. Outcomes vary widely based on number of metastatic sites, whether metastases can be surgically removed, RAS/BRAF/MSI status, and access to targeted therapy or immunotherapy.
The American Cancer Society recommends regular screening starting at age 45 for people at average risk. Those with higher risk factors may need to start earlier.
Immunotherapy drugs like pembrolizumab and nivolumab are especially effective for colorectal cancers with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) status. Ask whether your tumor has been tested.
Research is ongoing, but factors may include changes in diet, obesity, sedentary lifestyle, and microbiome alterations. Cases in people under 50 have been rising for several decades.

Related research & insights

You’re not alone

Looking for colorectal cancer treatment options?

A patient navigator can help you explore treatment pathways, find clinical trials near you, and connect with specialists who see colorectal cancer every day. Free, confidential consultation.

Send a message
Free callback

Talk to a navigator

Leave your details and we’ll call you at your preferred time.